# REGENXBIO Inc.: Form 8-K, filed Mar 20, 2026

- Company: [REGENXBIO Inc.](/companies/rgnx.md) (CIK 1590877)
- Form: 8-K
- Filed: 2026-03-20
- Accepted by EDGAR: Mar 20, 2026, 17:15 ET
- Period: 2026-03-18
- Accession: 0001193125-26-117913
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1590877/000119312526117913/rgnx-20260318.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1590877/000119312526117913/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1590877/000119312526117913/rgnx-20260318.htm

Filed Mar 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-117913. Last ingested by Listed: Nov 10, 2026, 17:27 ET. No prices; not investment advice.
